Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2017

Dec 18, 2017

5262_dirs_2017-12-18_97f730f4-5a0f-4971-888f-dd91c4dae2d9.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6976Z

GlaxoSmithKline PLC

18 December 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr P J T Vallance

b)

Position/status

President, R&D

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882   

b)

Nature of the transaction

Sale of 20,000 Ordinary shares on 18 December 2017 at a price of £13.1044.

c)

Price(s) and volume(s)

Price(s) Volume(s)
£13.1044 20,000

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2017-12-18

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mrs S Vallance

b)

Position/status

PCA of Dr P J T Vallance (President, R&D)

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882 

b)

Nature of the transaction

Sale of 32,974 Ordinary shares on 18 December 2017 at a price of £13.0911

c)

Price(s) and volume(s)

Price(s) Volume(s)
£13.0911 32,974

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2017-12-18

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQVLFFDLFFFBV